DK1863920T3 - Fremgangsmåde til forbedret isolering af rekombinant producerede proteiner - Google Patents
Fremgangsmåde til forbedret isolering af rekombinant producerede proteinerInfo
- Publication number
- DK1863920T3 DK1863920T3 DK06725404.5T DK06725404T DK1863920T3 DK 1863920 T3 DK1863920 T3 DK 1863920T3 DK 06725404 T DK06725404 T DK 06725404T DK 1863920 T3 DK1863920 T3 DK 1863920T3
- Authority
- DK
- Denmark
- Prior art keywords
- recombinantly produced
- produced proteins
- improved isolation
- protein
- peptone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05102475A EP1707634A1 (en) | 2005-03-29 | 2005-03-29 | Method for isolation of recombinantly produced proteins |
PCT/EP2006/061148 WO2006103258A1 (en) | 2005-03-29 | 2006-03-29 | Method for improved isolation of recombinantly produced proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1863920T3 true DK1863920T3 (da) | 2011-03-14 |
Family
ID=35063154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06725404.5T DK1863920T3 (da) | 2005-03-29 | 2006-03-29 | Fremgangsmåde til forbedret isolering af rekombinant producerede proteiner |
Country Status (10)
Country | Link |
---|---|
US (2) | US9388402B2 (da) |
EP (4) | EP1707634A1 (da) |
AT (1) | ATE490336T1 (da) |
DE (1) | DE602006018587D1 (da) |
DK (1) | DK1863920T3 (da) |
ES (1) | ES2354715T3 (da) |
PL (1) | PL1863920T3 (da) |
PT (1) | PT1863920E (da) |
SI (1) | SI1863920T1 (da) |
WO (1) | WO2006103258A1 (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007101681A1 (en) * | 2006-03-07 | 2007-09-13 | Baxter International Inc | Highly phosphorylated and sulfated recombinant factor ix |
EP2004671B1 (en) * | 2006-03-30 | 2015-12-09 | Novo Nordisk A/S | Two-phase precipitation of proteins |
PT2495307T (pt) | 2006-07-13 | 2018-05-10 | Wyeth Llc | Produção do fator ix de coagulação com padrão melhorado de glicosilação |
EP1988101A1 (en) | 2007-05-04 | 2008-11-05 | Novo Nordisk A/S | Improvement of factor VIII polypeptide titers in cell cultures |
EP2167526B1 (en) | 2007-07-11 | 2011-03-30 | Novo Nordisk A/S | Purification of factor viii using a mixed-mode or multimodal resin |
EP2027875A1 (en) * | 2007-08-23 | 2009-02-25 | Octapharma AG | A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC) |
BRPI0821474B8 (pt) * | 2007-12-28 | 2021-05-25 | Baxalta GmbH | formulação farmacêutica líquida estável |
US11197916B2 (en) | 2007-12-28 | 2021-12-14 | Takeda Pharmaceutical Company Limited | Lyophilized recombinant VWF formulations |
SI2300497T1 (sl) | 2008-06-24 | 2013-02-28 | Octapharma Ag | Postopek za äťiĺˇäťenje koagulacijskega faktorja viii |
AU2009284113B2 (en) | 2008-08-21 | 2015-05-14 | Octapharma Ag | Recombinantly produced human factor VIII and IX |
TWI508735B (zh) | 2008-10-21 | 2015-11-21 | 巴克斯特國際公司 | 凍乾的重組vwf調配物 |
CA2793143C (en) | 2010-03-30 | 2020-04-28 | Gustav Gilljam | Process for the purification of a growth factor protein |
JP5876868B2 (ja) * | 2010-03-30 | 2016-03-02 | オクタファルマ・アーゲー | 第ix凝固因子などのビタミンk依存性タンパク質の精製方法 |
US9428727B2 (en) | 2010-04-26 | 2016-08-30 | Novartis Ag | Cell culture medium |
CN103154233A (zh) | 2010-10-05 | 2013-06-12 | 诺沃—诺迪斯克保健股份有限公司 | 生产蛋白质的方法 |
US9115381B2 (en) | 2011-05-13 | 2015-08-25 | Octapharma Ag | Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIII |
JP5640189B2 (ja) | 2011-06-17 | 2014-12-17 | 学校法人東日本学園 | ループスアンチコアグラント検出用血液凝固時間の測定方法 |
KR101439634B1 (ko) * | 2012-10-26 | 2014-09-15 | 주식회사 바이오에프디엔씨 | 항균펩타이드 베타 디펜신 3 및 그 유사체의 재조합 단백질로의 대량 생산 방법 |
EP3875106A1 (en) * | 2013-08-08 | 2021-09-08 | Bioverativ Therapeutics Inc. | Purification of chimeric fviii molecules |
GB201420139D0 (en) | 2014-11-12 | 2014-12-24 | Ucl Business Plc | Factor IX gene therapy |
BR102015012334A2 (pt) | 2015-05-27 | 2016-11-29 | Fundação Hemoct De Ribeirão Preto Fundherp | processo de produção do fator vii de coagulação sanguínea e fator vii de coagulação sanguínea |
TW201738256A (zh) * | 2016-04-04 | 2017-11-01 | 日產化學工業股份有限公司 | 蛋白質產生方法 |
WO2018210771A1 (en) | 2017-05-17 | 2018-11-22 | Octapharma Ag | Method for the production of a recombinant target protein |
CN107470012B (zh) * | 2017-07-05 | 2020-04-07 | 昆明理工大学 | 一种磷灰石纯矿物的提取方法 |
US10842885B2 (en) | 2018-08-20 | 2020-11-24 | Ucl Business Ltd | Factor IX encoding nucleotides |
HUE065504T2 (hu) * | 2018-11-30 | 2024-05-28 | Amgen Inc | Rendszerek és eljárások citopatogén hatás detektálására sejtekben |
CN111208239B (zh) * | 2020-02-25 | 2022-10-18 | 浙江工业大学 | 一种键合态香气物质的除杂纯化方法 |
CN111793595A (zh) * | 2020-07-23 | 2020-10-20 | 上海奥浦迈生物科技有限公司 | 一种hek293细胞无血清培养基 |
CN115299584B (zh) * | 2022-08-10 | 2024-04-02 | 广东省广盐集团股份有限公司 | 一种具有减盐效果的盐微粒的制备方法及应用 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5045455A (en) | 1984-01-12 | 1991-09-03 | Chiron Corporation | Factor VIII:C cDNA cloning and expression |
ATE78871T1 (de) | 1984-01-12 | 1992-08-15 | Chiron Corp | Proteinzusammensetzung mit koagulations-wirkung und verfahren zu ihrer herstellung. |
IL74909A (en) | 1984-04-20 | 1992-01-15 | Genentech Inc | Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein |
JPS6171774A (ja) | 1984-09-14 | 1986-04-12 | Sony Corp | テレビジヨンカメラ装置のビ−ム電流制御装置 |
ES8801674A1 (es) | 1985-04-12 | 1988-02-16 | Genetics Inst | Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante. |
ATE74164T1 (de) | 1985-04-22 | 1992-04-15 | Genetics Inst | Herstellung mit hoher leistung des aktivfaktors ix. |
WO1987004187A1 (en) | 1986-01-03 | 1987-07-16 | Genetics Institute, Inc. | METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
FI98829C (fi) | 1986-01-27 | 1997-08-25 | Chiron Corp | Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta |
US5595886A (en) | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
US5451521A (en) | 1986-05-29 | 1995-09-19 | Genetics Institute, Inc. | Procoagulant proteins |
EP0251843A1 (fr) | 1986-06-06 | 1988-01-07 | Transgene S.A. | Procédé de préparation de facteur VIII à partir de cellules de mammifères |
DK155388C (da) | 1986-07-08 | 1989-10-23 | Palle Pedersen | Laas |
EP0254076B1 (en) | 1986-07-11 | 1991-05-08 | Miles Inc. | Improved recombinant protein production |
NO872932L (no) | 1986-07-18 | 1988-01-19 | Gist Brocades Nv | Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika. |
IL84168A0 (en) | 1986-10-15 | 1988-03-31 | Rorer Int Overseas | Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same |
US4980456A (en) | 1987-04-06 | 1990-12-25 | Scripps Clinic And Research Foundation | Recombinant factor VIIIC derived fragments |
EP0294910B1 (en) | 1987-06-12 | 1996-09-11 | Immuno Ag | Novel proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
FR2619314B1 (fr) | 1987-08-11 | 1990-06-15 | Transgene Sa | Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant |
FR2638643B1 (fr) | 1988-11-09 | 1991-04-12 | Transgene Sa | Sequence d'adn codant pour le facteur ix humain ou une proteine analogue, vecteur d'expression, cellules transformees, procede de preparation du facteur ix et produits obtenus correspondants |
US5055555A (en) | 1989-01-05 | 1991-10-08 | Helmut Sassenfeld | Purification of G-CSF |
EP0500734B1 (en) | 1989-11-17 | 1998-02-11 | Novo Nordisk A/S | Protein complexes having factor viii:c activity and production thereof |
SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5770561A (en) * | 1993-07-14 | 1998-06-23 | Xoma Corporation | Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products |
DK128093D0 (da) | 1993-11-12 | 1993-11-12 | Novo Nordisk As | Hidtil ukendte forbindelser |
SE9403915D0 (sv) | 1994-11-14 | 1994-11-14 | Annelie Almstedt | Process A |
US5851800A (en) | 1996-05-14 | 1998-12-22 | Pharmacia & Upjohn Ab | Process for producing a protein |
US20020012991A1 (en) * | 1997-04-07 | 2002-01-31 | Florence Chua Nee Ho Kit Fong | Cell culture media for enhanced protein production |
US5804420A (en) * | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
WO2000049147A1 (en) | 1999-02-19 | 2000-08-24 | Octagene Gmbh | Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
US6338964B1 (en) | 1999-05-07 | 2002-01-15 | Bayer Corporation | Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration |
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
NZ517215A (en) * | 1999-08-25 | 2004-01-30 | Immunex Corp | Compositions and methods for improved cell culture |
SI1266006T1 (sl) | 2000-03-22 | 2006-06-30 | Octagene Gmbh | Proizvodnja rekombinantnih muteinov krvnega koagulacijskega faktorja VIII v humanih celicnih linijah |
US20050227920A1 (en) * | 2003-12-11 | 2005-10-13 | Xinli Lin | Methods for production of recombinant vascular endothelial cell growth inhibitor |
-
2005
- 2005-03-29 EP EP05102475A patent/EP1707634A1/en not_active Withdrawn
-
2006
- 2006-03-29 DE DE602006018587T patent/DE602006018587D1/de active Active
- 2006-03-29 PL PL06725404T patent/PL1863920T3/pl unknown
- 2006-03-29 EP EP06725404A patent/EP1863920B1/en not_active Revoked
- 2006-03-29 DK DK06725404.5T patent/DK1863920T3/da active
- 2006-03-29 WO PCT/EP2006/061148 patent/WO2006103258A1/en active Application Filing
- 2006-03-29 SI SI200630931T patent/SI1863920T1/sl unknown
- 2006-03-29 AT AT06725404T patent/ATE490336T1/de active
- 2006-03-29 ES ES06725404T patent/ES2354715T3/es active Active
- 2006-03-29 US US11/887,677 patent/US9388402B2/en active Active
- 2006-03-29 EP EP20100181019 patent/EP2258860A1/en not_active Withdrawn
- 2006-03-29 PT PT06725404T patent/PT1863920E/pt unknown
- 2006-03-29 EP EP18185708.7A patent/EP3467116A1/en not_active Withdrawn
-
2016
- 2016-06-30 US US15/199,585 patent/US10626431B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2354715T3 (es) | 2011-03-17 |
EP2258860A1 (en) | 2010-12-08 |
DE602006018587D1 (de) | 2011-01-13 |
US20090088370A1 (en) | 2009-04-02 |
EP1863920A1 (en) | 2007-12-12 |
ATE490336T1 (de) | 2010-12-15 |
SI1863920T1 (sl) | 2011-03-31 |
EP3467116A1 (en) | 2019-04-10 |
US10626431B2 (en) | 2020-04-21 |
PL1863920T3 (pl) | 2011-05-31 |
EP1863920B1 (en) | 2010-12-01 |
US9388402B2 (en) | 2016-07-12 |
EP1707634A1 (en) | 2006-10-04 |
WO2006103258A1 (en) | 2006-10-05 |
US20170183703A1 (en) | 2017-06-29 |
PT1863920E (pt) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1863920T3 (da) | Fremgangsmåde til forbedret isolering af rekombinant producerede proteiner | |
BR122019022434B8 (pt) | método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular | |
PE20140867A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso | |
EA201100146A1 (ru) | Растения, имеющие улучшенные характеристики урожайности, и способ их получения | |
EA201070057A1 (ru) | Новый ген bacillus thuringiensis с активностью против чешуекрылых | |
AR078964A1 (es) | Gen de bacillus thuringiensis que codifica polipeptido con actividad pesticida contra lepidoptera | |
Kawamoto et al. | Proteomic studies of an Antarctic cold-adapted bacterium, Shewanella livingstonensis Ac10, for global identification of cold-inducible proteins | |
DK1929001T3 (da) | Nye dehydrogenaser, disses derivater og en fremgangsmåde til fremstilling af optisk aktive alkanoler | |
EA201270035A1 (ru) | Растения с улучшенными характеристиками урожайности и способ их получения | |
BRPI0516572A (pt) | métodos e composições para melhorar a produção de proteìnas recombinantes | |
DK1543106T3 (da) | Fremgangsmåder og medier til kontrol af sialylering af proteiner, der dannes af mammaliaceller | |
AR054599A1 (es) | Proteccion de la proteina krp mutante negativa dominante contra una inhibicion activa del complejo cdk -ciclina por la krp de tipo salvaje | |
EP2395091A3 (en) | Plants having enhanced yield-related traits and a method for making the same | |
EA201170961A1 (ru) | Новый ген bacillus thuringiensis с активностью против lepidoptera | |
DK1874932T3 (da) | Produktion af rekombinante proteiner ved autoproteolytisk spaltning af et fusionsprotein | |
EP2599870A3 (en) | Plants having enhanced yield-related traits and a method for making the same | |
UA92157C2 (ru) | Способ продуцирования гормона роста | |
MX2012003451A (es) | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para prepararlas. | |
WO2010023320A3 (en) | Plants having enhanced yield-related traits and a method for making the same | |
AU2008220715A8 (en) | Plants having enhanced yield-related traits and a method for making the same | |
WO2006113475A3 (en) | Methods and compositions to modulate adhesion and stress tolerance in bacteria | |
DK1549735T3 (da) | Cirkulært DNA-molekyle med et konditionelt replikationsstartssted, fremgangsmåde til fremstilling heraf og anvendelse af disse til genterapi | |
DE60307615D1 (de) | Zellkulturmedium | |
AR070143A1 (es) | Gen de bacillus thuringiensis (bt) con actividad contra coleopteros | |
EA201290936A1 (ru) | Растения с улучшенными характеристиками урожайности и способ их получения |